**Core Concept**
Nesidioblastosis is a rare condition characterized by the excessive growth of pancreatic beta cells, leading to inappropriate insulin secretion and hypoglycemia. This condition often presents in infancy or early childhood but can also occur in adults. The pathophysiology involves an abnormal regulation of insulin secretion, which is usually triggered by an intrinsic defect in the beta cells.

**Why the Correct Answer is Right**
Nesidioblastosis is often associated with a genetic predisposition, and mutations in genes such as GCK, ABCC8, and KCNJ11 can contribute to the development of this condition. The excessive insulin secretion in nesidioblastosis is usually resistant to glucose levels, leading to hypoglycemia even in the presence of elevated glucose levels. The condition can be challenging to diagnose and may require a combination of clinical, biochemical, and imaging studies.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because nesidioblastosis is not typically associated with a family history of the condition. While genetic predisposition can play a role, the condition often presents de novo in infants and children.

**Option B:** This option is incorrect because nesidioblastosis is not typically responsive to diazoxide, a medication that inhibits insulin secretion. In fact, diazoxide can worsen hypoglycemia in patients with nesidioblastosis.

**Option C:** This option is incorrect because nesidioblastosis is not typically associated with a significant increase in pancreatic volume. Imaging studies may show a normal or slightly enlarged pancreas, but significant pancreatic enlargement is not a characteristic feature of this condition.

**Clinical Pearl / High-Yield Fact**
Nesidioblastosis is a rare but important cause of hypoglycemia in infants and children. It can be challenging to diagnose and may require a combination of clinical, biochemical, and imaging studies. A high index of suspicion is necessary to diagnose this condition, especially in infants and children presenting with recurrent hypoglycemia.

**Correct Answer:** A.